VSUL - Visualant, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.22
0.00 (0.00%)
At close: 9:44AM EST
Stock chart is not supported by your current browser
Previous Close0.22
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume2,016
Market Cap860,305
Beta0.62
PE Ratio (TTM)N/A
EPS (TTM)-1.32
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Visualant, Inc. :VSUL-US: Earnings Analysis: Q3, 2017 By the Numbers : August 17, 2017
    Capital Cube3 months ago

    Visualant, Inc. :VSUL-US: Earnings Analysis: Q3, 2017 By the Numbers : August 17, 2017

    Categories: Yahoo FinanceGet free summary analysis Visualant, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Visualant, Inc. – Mesa Laboratories, Inc., AMETEK, Inc., MKS Instruments, Inc., Cognex Corporation, Mace Security International, Inc., ESCO Technologies Inc. and Schmitt Industries, Inc. (MLAB-US, AME-US, MKSI-US, CGNX-US, MACE-US, ... Read more (Read more...)

  • Business Wire4 months ago

    Visualant Appoints Phillip Bosua as Chief Product Officer

    Visualant, Inc. – a provider of chromatic-based identification, authentication and diagnostic solutions, with its ChromaID™ technology, announced today that Phillip Bosua, currently a member of its Scientific Advisory Board, has become Chief Product Officer of the Company.

  • Visualant, Inc. :VSUL-US: Earnings Analysis: Q2, 2017 By the Numbers : May 24, 2017
    Capital Cube6 months ago

    Visualant, Inc. :VSUL-US: Earnings Analysis: Q2, 2017 By the Numbers : May 24, 2017

    Categories: Yahoo FinanceGet free summary analysis Visualant, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Visualant, Inc. – AMETEK, Inc., MKS Instruments, Inc., Cognex Corporation, Mace Security International, Inc., ESCO Technologies Inc. and Schmitt Industries, Inc. (AME-US, MKSI-US, CGNX-US, MACE-US, ESE-US and SMIT-US) that ... Read more (Read more...)

  • Business Wire7 months ago

    Visualant Granted Biological Tissue Patent

    Visualant, Incorporated – an emerging leader in next-generation optical sensor technology – announced today that it has received its 11th U.S. patent. The invention relates to the use of the company’s disruptive ChromaID™ technology for identifying and analyzing biological tissue, and has many potential applications in healthcare, food safety, cosmetics and other medical, industrial and consumer markets....

  • Business Wire7 months ago

    Visualant Appoints Phillip Bosua to Scientific Advisory Board

    Visualant, Inc. – a provider of chromatic-based identification, authentication and diagnostic solutions, with its patented ChromaID™ technology, announced today that it has appointed Phillip Bosua to its Scientific Advisory Board.

  • Visualant, Inc. :VSUL-US: Earnings Analysis: Q1, 2017 By the Numbers : March 13, 2017
    Capital Cube8 months ago

    Visualant, Inc. :VSUL-US: Earnings Analysis: Q1, 2017 By the Numbers : March 13, 2017

    Categories: Yahoo Finance Get free summary analysis Visualant, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Visualant, Inc. – MKS Instruments, Inc., Mesa Laboratories, Inc., AMETEK, Inc., Cognex Corporation, Mace Security International, Inc. and ESCO Technologies Inc. (MKSI-US, MLAB-US, AME-US, CGNX-US, MACE-US and ESE-US) that ... Read more (Read more...)

  • Business Wire9 months ago

    Visualant Announces Shareholder Update

    Visualant, Inc. – a provider of chromatic-based identification, authentication and diagnostic solutions, with its ChromaID™ technology, released today a letter from its Founder and Chief Executive Officer providing an overview of the Company’s technology and an update on recent activities of the Company.

  • Business Wirelast year

    Visualant and BIOMEDX Sign Joint Development Agreement

    Visualant, Inc. – a photonics technology development company providing chromatic-based identification, authentication and diagnostic solutions, with its ChromaID™ technology, announced today that it has entered into a Joint Development Agreement with BIOMEDX Group, Inc., to develop its ChromaID technology as an exclusive analytical photonic tool for Aesthetics, Dermatology and Plastic Surgery.